Browse studies

Find your next paid study

25 recruiting studies matching your filters

A Phase IIa, Open-label, Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination With Venetoclax Plus Decitabine in Patients With AML Who Are Ineligible for Intensive Induction Therapy

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete R…

Acute Myeloid Leukemia (AML)

Estimated

~$10 – $8,750

Bio-Path Holdings, Inc.NCT02781883